Showing 1 - 10 of 299
Using individual level-data, the paper uncovers patient and drug characteristics that determine the probability of using the original patented products despite the presence of generic substitutes in the Czech Republic in the period 2009-2013. Our results reveal different behavioral patterns for...
Persistent link: https://www.econbiz.de/10011432132
Persistent link: https://www.econbiz.de/10012372762
Persistent link: https://www.econbiz.de/10012253820
I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...
Persistent link: https://www.econbiz.de/10011954334
Persistent link: https://www.econbiz.de/10011999624
Markets require informed participants to function efficiently. This paper examines the impact of providing targeted information directly to patients on their purchasing-decisions regarding pharmaceutical drugs. We analyze the effect of informational letters sent by a Swiss health insurer to...
Persistent link: https://www.econbiz.de/10014545146
Persistent link: https://www.econbiz.de/10011377471
Objective: To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of reference pricing on prior implemented generic substitution is assessed....
Persistent link: https://www.econbiz.de/10010528479
Persistent link: https://www.econbiz.de/10009762378
Persistent link: https://www.econbiz.de/10010257969